Literature DB >> 22626820

A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.

Talat H Malik1, Peter J Lavin, Elena Goicoechea de Jorge, Katherine A Vernon, Kirsten L Rose, Mitali P Patel, Marcel de Leeuw, John J Neary, Peter J Conlon, Michelle P Winn, Matthew C Pickering.   

Abstract

Controlled activation of the complement system, a key component of innate immunity, enables destruction of pathogens with minimal damage to host tissue. Complement factor H (CFH), which inhibits complement activation, and five CFH-related proteins (CFHR1-5) compose a family of structurally related molecules. Combined deletion of CFHR3 and CFHR1 is common and confers a protective effect in IgA nephropathy. Here, we report an autosomal dominant complement-mediated GN associated with abnormal increases in copy number across the CFHR3 and CFHR1 loci. In addition to normal copies of these genes, affected individuals carry a unique hybrid CFHR3-1 gene. In addition to identifying an association between these genetic observations and complement-mediated kidney disease, these results provide insight into the protective role of the combined deletion of CFHR3 and CFHR1 in IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22626820      PMCID: PMC3380655          DOI: 10.1681/ASN.2012020166

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  18 in total

1.  A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.

Authors:  Nigel J Francis; Bairbre McNicholas; Atif Awan; Mary Waldron; Donal Reddan; Denise Sadlier; David Kavanagh; Lisa Strain; Kevin J Marchbank; Claire L Harris; Timothy H J Goodship
Journal:  Blood       Date:  2011-11-04       Impact factor: 22.113

2.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.

Authors:  Anne E Hughes; Nick Orr; Hossein Esfandiary; Martha Diaz-Torres; Timothy Goodship; Usha Chakravarthy
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

3.  Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes.

Authors:  D A Male; R J Ormsby; S Ranganathan; E Giannakis; D L Gordon
Journal:  Mol Immunol       Date:  2000 Jan-Feb       Impact factor: 4.407

4.  Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.

Authors:  Gregory S Hageman; Lisa S Hancox; Andrew J Taiber; Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Monte J Radeke; David Kavanagh; Anna Richards; John Atkinson; Seppo Meri; Julie Bergeron; Jana Zernant; Joanna Merriam; Bert Gold; Rando Allikmets; Michael Dean
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

5.  Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.

Authors:  Jennifer L McRae; Thomas G Duthy; Kim M Griggs; Rebecca J Ormsby; Peter J Cowan; Brett A Cromer; William J McKinstry; Michael W Parker; Brendan F Murphy; David L Gordon
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

6.  Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1.

Authors:  John J Neary; Peter J Conlon; David Croke; Anthony Dorman; Mary Keogan; Feng Yu Zhang; Jeffery M Vance; Margaret A Pericak-Vance; William K Scott; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2002-08       Impact factor: 10.121

7.  Familial membranoproliferative glomerulonephritis type III.

Authors:  John Neary; Anthony Dorman; Eileen Campbell; Mary Keogan; Peter Conlon
Journal:  Am J Kidney Dis       Date:  2002-07       Impact factor: 8.860

Review 8.  Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.

Authors:  S Rodríguez de Córdoba; E Goicoechea de Jorge
Journal:  Clin Exp Immunol       Date:  2008-01       Impact factor: 4.330

9.  Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.

Authors:  Stefan Heinen; Andrea Hartmann; Nadine Lauer; Ulrike Wiehl; Hans-Martin Dahse; Sylvia Schirmer; Katharina Gropp; Tina Enghardt; Reinhard Wallich; Steffi Hälbich; Michael Mihlan; Ursula Schlötzer-Schrehardt; Peter F Zipfel; Christine Skerka
Journal:  Blood       Date:  2009-06-15       Impact factor: 22.113

10.  Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.

Authors:  Julian P Venables; Lisa Strain; Danny Routledge; David Bourn; Helen M Powell; Paul Warwicker; Martha L Diaz-Torres; Anne Sampson; Paul Mead; Michelle Webb; Yves Pirson; Michael S Jackson; Anne Hughes; Katrina M Wood; Judith A Goodship; Timothy H J Goodship
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

View more
  63 in total

Review 1.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

2.  American Society of Nephrology clinical pathological conference.

Authors:  Kevin E Meyers; Helen Liapis; Mohamed G Atta
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 8.237

Review 3.  CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Authors:  Peter F Zipfel; Thorsten Wiech; Emma D Stea; Christine Skerka
Journal:  J Am Soc Nephrol       Date:  2020-01-24       Impact factor: 10.121

4.  Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.

Authors:  Jennifer Laskowski; Brandon Renner; Moglie Le Quintrec; Sarah Panzer; Jonathan P Hannan; Danica Ljubanovic; Marieta M Ruseva; Dorin-Bogdan Borza; Alexandra H Antonioli; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2016-05-07       Impact factor: 10.612

5.  C3 glomerulopathy: clinicopathologic features and predictors of outcome.

Authors:  Nicholas R Medjeral-Thomas; Michelle M O'Shaughnessy; John A O'Regan; Carol Traynor; Michael Flanagan; Limy Wong; Chia Wei Teoh; Atif Awan; Mary Waldron; Tom Cairns; Patrick O'Kelly; Anthony M Dorman; Matthew C Pickering; Peter J Conlon; H Terence Cook
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

Review 6.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

7.  Detection of Genetic Rearrangements in the Regulators of Complement Activation RCA Cluster by High-Throughput Sequencing and MLPA.

Authors:  Jesús García-Fernández; Susana Vilches-Arroyo; Leticia Olavarrieta; Julián Pérez-Pérez; Santiago Rodríguez de Córdoba
Journal:  Methods Mol Biol       Date:  2021

Review 8.  Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.

Authors:  Krzysztof Kiryluk; Jan Novak; Ali G Gharavi
Journal:  Annu Rev Med       Date:  2012-10-16       Impact factor: 13.739

Review 9.  The genetics and immunobiology of IgA nephropathy.

Authors:  Krzysztof Kiryluk; Jan Novak
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

10.  Dimerization of complement factor H-related proteins modulates complement activation in vivo.

Authors:  Elena Goicoechea de Jorge; Joseph J E Caesar; Talat H Malik; Mitali Patel; Matthew Colledge; Steven Johnson; Svetlana Hakobyan; B Paul Morgan; Claire L Harris; Matthew C Pickering; Susan M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.